Curamir Therapeutics
Curamir Therapeutics is a developer of miRNA-based cancer therapeutics.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Curamir Therapeutics Information
Geographic Data
Address:
City: Woburn
State: Massachusetts
Zip:
Country: United States
Financial Info
Stage:
series a
Raised Last:
$10M
Raised Total:$10M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Curamir is a Woburn, MA-based biotechnology company launched and incubated by Delos Capital with an initial academic licensing from SUNY. Through its proprietary miRNA engineering platform and insights into cancer biology, Curamir develops miRNA-based cancer therapeutics with enhanced safety, potency and stability. Its novel approach addresses current challenges associated with both chemoresistance in cancer and effective systemic delivery of miRNA mimics.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2019 | Series A | $0 |
Delos Capital Delos Capital |
9/2019 | Series A | 1 | $10M |
Delos Capital Delos Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
